Transgene to Participate in Upcoming Meetings with Biotech Industry Leaders

Strasbourg (France), June 13, 2025, 8:30 a.m. CET – Transgene(Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, todayannounced that its management team will meet institutional investors, scientists and leaders of the biotechnology ecosystem during the upcoming editions of : BIO International Convention 2025, on June 16, in Boston, US; Portzamparc – 2025 Mid&Small Caps Conference(hosted byBNP Paribas...

Illkirch Graffenstaden, 13/06/2025 (informazione.news - comunicati stampa - economia)

(Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today :

Following the at the American Society of Clinical Oncology ( ) Annual Meeting (see press release ), Transgene together with , MD, PhD, FRCP (University of Liverpool, La Jolla Institute for Immunology), have discussed the in a available on Transgene website and .

***

myvac®
myvac® myvac

Attachment